Gemfibrozil
- 1 September 1988
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 36 (3) , 314-339
- https://doi.org/10.2165/00003495-198836030-00004
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- The Effect of Renal Function on the Pharmacokinetics of GemfibrozilThe Journal of Clinical Pharmacology, 1987
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- A Comparison of different formulations and dosage administrations of gemfibrozilThe American Journal of Cardiology, 1986
- Clinical results with gemfibrozil and background to the Helsinki Heart StudyThe American Journal of Cardiology, 1983
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- Gemfibrozil in the Treatment of Dyslipidaemia A 5‐year follow‐up studyActa Medica Scandinavica, 1982
- Plasma Prekallikrein, Kallikrein Inhibitors, Kininogen and Lipids during Gemfibrozil Treatment in Type II DyslipidaemiaActa Medica Scandinavica, 1982
- Gemfibrozil in the Treatment of Dyslipidaemias in Middle‐Aged Male Survivors of Myocardial InfarctionActa Medica Scandinavica, 1981
- Clofibrate therapy and gallstone inductionDigestive Diseases and Sciences, 1978
- Gallbladder Disease as a Side Effect of Drugs Influencing Lipid Metabolism Experience in the Coronary Drug ProjectNew England Journal of Medicine, 1977